Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti–CTLA-4 antibody

Anti–CTLA-4 mAb is efficacious in enhancing tumor immunity in humans. CTLA-4 is expressed by conventional T cells upon activation and by naturally occurring FOXP3(+)CD4(+) Treg cells constitutively, raising a question of how anti–CTLA-4 mAb can differentially control these functionally opposing T ce...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Proc Natl Acad Sci U S A
Main Authors: Ha, Danbee, Tanaka, Atsushi, Kibayashi, Tatsuya, Tanemura, Atsushi, Sugiyama, Daisuke, Wing, James Badger, Lim, Ee Lyn, Teng, Karen Wei Weng, Adeegbe, Dennis, Newell, Evan W., Katayama, Ichiro, Nishikawa, Hiroyoshi, Sakaguchi, Shimon
Formato: Artigo
Idioma:Inglês
Publicado em: National Academy of Sciences 2019
Assuntos:
PNAS Plus
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6329979/
https://ncbi.nlm.nih.gov/pubmed/30587582
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1812186116
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados